Boxer Capital’s ESSA Pharma EPIX Stock Holding History

Boxer Capital’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-724,500	Closed	-$2.28M	–	77
2022 Q2	$2.28M	Hold	724,500	–	–	0.14%	65
2022 Q1	$4.49M	Hold	724,500	–	–	0.23%	58
2021 Q4	$10.3M	Buy	724,500 +37,500	+5%	+$418K	0.4%	46
2021 Q3	$5.5M	Hold	687,000	–	–	0.19%	67
2021 Q2	$19.6M	Hold	687,000	–	–	0.69%	45
2021 Q1	$20M	Buy	+687,000	New	+$16M	0.68%	42
2016 Q4	–	Sell	-1,405	Closed	-$74K	–	31
2016 Q3	$74K	Hold	1,405	–	–	0.03%	28
2016 Q2	$83K	Hold	1,405	–	–	0.07%	23
2016 Q1	$91K	Hold	1,405	–	–	0.09%	21
2015 Q4	$119K	Buy	+1,405	New	+$147K	0.1%	15

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Boxer Capital's EPIX Position: Q3 2022 in Review

Boxer Capital sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 724,500 shares — an estimated $2.28M sold.

Boxer Capital first reported a position in EPIX in Q4 2015 and held it in 10 quarters. The position peaked at $20M in Q1 2021. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.

Boxer Capital reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
Boxer Capital sold 724,500 ESSA Pharma shares in Q3 2022, an estimated $2.28M.
Boxer Capital first reported a position in ESSA Pharma in Q4 2015 and held it in 10 quarters.
Boxer Capital's ESSA Pharma position peaked at $20M in Q1 2021.
54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.

Based on Boxer Capital's 13F filing for Q3 2022, filed 14 Nov 2022.